300633 开立医疗
已收盘 10-14 15:00:00
资讯
新帖
简况
开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%
证券之星 · 18:24
开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%
开立医疗(300633)10月13日主力资金净买入43.34万元
证券之星 · 09:14
开立医疗(300633)10月13日主力资金净买入43.34万元
开立医疗(300633)披露2026年股票期权激励计划授予登记完成公告,9月22日股价上涨0.81%
证券之星 · 09-22
开立医疗(300633)披露2026年股票期权激励计划授予登记完成公告,9月22日股价上涨0.81%
开立医疗新注册《开立ST1UD0127D1系列便携式彩色超声多普勒系统软件V1.0》项目的软件著作权
证券之星 · 09-12
开立医疗新注册《开立ST1UD0127D1系列便携式彩色超声多普勒系统软件V1.0》项目的软件著作权
开立医疗新提交“iMetry”、“iChromo”等3件商标注册申请
证券之星 · 09-11
开立医疗新提交“iMetry”、“iChromo”等3件商标注册申请
开立医疗公布国际专利申请:“头端部以及具有该头端部的内窥镜”
证券之星 · 09-11
开立医疗公布国际专利申请:“头端部以及具有该头端部的内窥镜”
股市必读:开立医疗新发布《董事会薪酬与考核委员会关于公司2026年股票期权激励计划激励对象名单的核查意见及公示情况说明》
证券之星 · 09-04
股市必读:开立医疗新发布《董事会薪酬与考核委员会关于公司2026年股票期权激励计划激励对象名单的核查意见及公示情况说明》
开立医疗:公司目前无需补税
证券之星 · 09-03
开立医疗:公司目前无需补税
研报掘金丨华源证券:维持开立医疗“买入”评级,微创外科、IVUS战略业务发展亮眼
格隆汇 · 08-26
研报掘金丨华源证券:维持开立医疗“买入”评级,微创外科、IVUS战略业务发展亮眼
8月24日开立医疗跌7.64%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 08-24
8月24日开立医疗跌7.64%,融通健康产业灵活配置混合A/B基金重仓该股
股市必读:开立医疗中报 - 第二季度单季净利润同比下降34.83%
证券之星 · 08-24
股市必读:开立医疗中报 - 第二季度单季净利润同比下降34.83%
开立医疗(300633)6月30日股东户数1.89万户,较上期增加3.17%
证券之星 · 08-22
开立医疗(300633)6月30日股东户数1.89万户,较上期增加3.17%
图解开立医疗中报:第二季度单季净利润同比下降34.83%
证券之星 · 08-22
图解开立医疗中报:第二季度单季净利润同比下降34.83%
开立医疗(300633)披露2026年股票期权激励计划(草案),8月21日股价下跌0.05%
证券之星 · 08-21
开立医疗(300633)披露2026年股票期权激励计划(草案),8月21日股价下跌0.05%
股市必读:开立医疗新发布《关于变更持续督导保荐代表人的公告》
证券之星 · 08-10
股市必读:开立医疗新发布《关于变更持续督导保荐代表人的公告》
开立医疗新注册《开立ED0128D1系列医用内窥镜图像处理器软件V1.0》项目的软件著作权
证券之星 · 08-08
开立医疗新注册《开立ED0128D1系列医用内窥镜图像处理器软件V1.0》项目的软件著作权
开立医疗(300633)披露关于变更持续督导保荐代表人的公告,8月7日股价上涨1.25%
证券之星 · 08-07
开立医疗(300633)披露关于变更持续督导保荐代表人的公告,8月7日股价上涨1.25%
开立医疗获得外观设计专利授权:“显示器(窄边框)”
证券之星 · 07-25
开立医疗获得外观设计专利授权:“显示器(窄边框)”
开立医疗获得实用新型专利授权:“一种医疗设备”
证券之星 · 07-24
开立医疗获得实用新型专利授权:“一种医疗设备”
开立医疗获得发明专利授权:“一种图像渲染方法、装置、电子设备及可读存储介质”
证券之星 · 07-11
开立医疗获得发明专利授权:“一种图像渲染方法、装置、电子设备及可读存储介质”
加载更多
公司概况
公司名称:
深圳开立生物医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2017-04-06
主营业务:
深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品以及心血管介入产品。截至报告期末,公司及其子公司已拥有境内外各项发明专利、实用新型专利及外观设计专利共计1254项,拥有软件著作权共344项、作品著作权30项,产品技术达到国内领先和国际先进水平。公司自2009年起被持续认定为“国家级高新技术企业”。
发行价格:
5.23
{"stockData":{"symbol":"300633","market":"SZ","secType":"STK","nameCN":"开立医疗","latestPrice":18.55,"timestamp":1791961395000,"preClose":18.66,"halted":0,"volume":3587200,"delay":0,"changeRate":-0.0059,"floatShares":260000000,"shares":425000000,"eps":0.3861,"marketStatus":"已收盘","change":-0.11,"latestTime":"10-14 15:00:00","open":18.6,"high":18.79,"low":18.31,"amount":66450800,"amplitude":0.0257,"askPrice":18.55,"askSize":7,"bidPrice":18.54,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.3861,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792027800000},"marketStatusCode":5,"adr":0,"adjPreClose":18.66,"symbolType":"stock","openAndCloseTimeList":[[1791941400000,1791948600000],[1791954000000,1791961200000]],"highLimit":20.53,"lowLimit":16.79,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":424837505,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":48.044548,"roe":"0.41%","epsLYR":0.46,"committee":0.475877,"marketValue":7881000000,"turnoverRate":0.0138,"status":1,"floatMarketCap":4825000000},"requestUrl":"/m/hq/s/300633","defaultTab":"news","newsList":[{"id":"2675439053","title":"开立医疗(300633)股东吴坤祥质押120万股,占总股本0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675439053","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675439053?lang=zh_cn&edition=full","pubTime":"2026-10-14 18:24","pubTimestamp":1791973471,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗10月14日公开信息显示,股东吴坤祥向中国中金财富证券有限公司合计质押120.0万股,占总股本0.28%。质押详情见下表:截止本公告日,股东吴坤祥已累计质押股份1100.0万股,占其持股总数的11.49%,股东陈志强已累计质押股份733.0万股,占其持股总数的7.66%,股东黄奕波已累计质押股份160.0万股,占其持股总数的7.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400033321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001069.SGD","SG9999001051.SGD","300633","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675399929","title":"开立医疗(300633)10月13日主力资金净买入43.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675399929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675399929?lang=zh_cn&edition=full","pubTime":"2026-10-14 09:14","pubTimestamp":1791940464,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月13日收盘,开立医疗报收于18.66元,下跌2.51%,换手率1.44%,成交量3.73万手,成交额6987.31万元。10月13日的资金流向数据方面,主力资金净流入43.34万元,占总成交额0.62%,游资资金净流入860.67万元,占总成交额12.32%,散户资金净流出904.01万元,占总成交额12.94%。融券方面,融券卖出4700.0股,融券偿还3.01万股,融券余量9.29万股,融券余额173.35万元。开立医疗主营业务:医疗诊断及治疗设备的自主研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400008343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001051.SGD","SG9999001069.SGD","300633","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148456","title":"开立医疗(300633)披露2026年股票期权激励计划授予登记完成公告,9月22日股价上涨0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148456","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148456?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070389,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘,开立医疗报收于19.85元,较前一交易日上涨0.81%,最新总市值为84.33亿元。公告显示,深圳开立生物医疗科技股份有限公司已完成2026年股票期权激励计划的授予登记工作。本次激励计划授予日为2026年9月14日,登记完成时间为2026年9月21日,共向322名激励对象授予698.20万份股票期权,行权价格为20.73元/份。本次授予登记的激励对象和数量与股东大会审议通过及公示情况一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","SG9999001051.SGD","SG9999006597.SGD","300633","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666793875","title":"开立医疗新注册《开立ST1UD0127D1系列便携式彩色超声多普勒系统软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2666793875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666793875?lang=zh_cn&edition=full","pubTime":"2026-09-12 02:27","pubTimestamp":1789151232,"startTime":"0","endTime":"0","summary":"证券之星消息,近日开立医疗(300633)新注册了《开立ST1UD0127D1系列便携式彩色超声多普勒系统软件V1.0》项目的软件著作权。今年以来开立医疗新注册软件著作权13个,较去年同期减少了18.75%。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了2.29亿元,同比减6.32%。通过天眼查大数据分析,深圳开立生物医疗科技股份有限公司共对外投资了12家企业,参与招投标项目2489次;财产线索方面有商标信息417条,专利信息1813条,著作权信息340条;此外企业还拥有行政许可297个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200001165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","BK0251","300633","SG9999001051.SGD","SG9999001069.SGD","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519009","title":"开立医疗新提交“iMetry”、“iChromo”等3件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666519009?lang=zh_cn&edition=full","pubTime":"2026-09-11 07:14","pubTimestamp":1789082067,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示,近日深圳开立生物医疗科技股份有限公司新提交“iMetry”、“iChromo”等3件商标注册申请。商标申请详情如下:今年以来深圳开立生物医疗科技股份有限公司新申请注册商标14件,截止目前公司共持有注册商标342件,另有163件商标尚在注册申请中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100013344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999001051.SGD","BK0251","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666519875","title":"开立医疗公布国际专利申请:“头端部以及具有该头端部的内窥镜”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666519875","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666519875?lang=zh_cn&edition=full","pubTime":"2026-09-11 06:03","pubTimestamp":1789077802,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示开立医疗(300633)公布了一项国际专利申请,专利名为“头端部以及具有该头端部的内窥镜”,专利申请号为PCT/CN2025/079340,国际公布日为2026年9月3日。专利详情如下:图片来源:世界知识产权组织(WIPO)今年以来开立医疗已公布的国际专利申请1个,较去年同期减少了75%。结合公司2026年中报财务数据,今年上半年公司在研发方面投入了2.29亿元,同比减6.32%。数据来源:企查查以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100011950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0251","300633","SG9999001051.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838806","title":"股市必读:开立医疗新发布《董事会薪酬与考核委员会关于公司2026年股票期权激励计划激励对象名单的核查意见及公示情况说明》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838806","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664838806?lang=zh_cn&edition=full","pubTime":"2026-09-04 01:45","pubTimestamp":1788457515,"startTime":"0","endTime":"0","summary":"截至2026年9月3日收盘,开立医疗报收于19.43元,下跌0.46%,换手率1.16%,成交量3.02万手,成交额5917.2万元。当日关注点交易信息汇总:9月3日主力资金净流出325.76万元,占总成交额5.51%。公司公告汇总:2026年股票期权激励计划激励对象名单公示期结束,未收到异议,董事会薪酬与考核委员会确认激励对象主体资格合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400002197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0251","300633","SG9999001051.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664824425","title":"开立医疗:公司目前无需补税","url":"https://stock-news.laohu8.com/highlight/detail?id=2664824425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664824425?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:06","pubTimestamp":1788419175,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗(300633)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,近期多家上市公司补税,同行澳华内镜也补了税,贵公司是否需要补税?近期董事长和总经理是在公司正常工作?开立医疗回复:您好,公司目前无需补税,公司董事长和总经理正常履职中,谢谢。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300022746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999006597.SGD","SG9999001051.SGD","BK0251","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756798","title":"研报掘金丨华源证券:维持开立医疗“买入”评级,微创外科、IVUS战略业务发展亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756798","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662756798?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:04","pubTimestamp":1787727865,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999006597.SGD","SG9999001051.SGD","300633","BK0251","161027","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224331","title":"8月24日开立医疗跌7.64%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224331?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:41","pubTimestamp":1787560861,"startTime":"0","endTime":"0","summary":"证券之星消息,8月24日开立医疗跌7.64%,收盘报19.11元,换手率3.68%,成交量9.57万手,成交额1.88亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为融通基金的融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400022130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001069.SGD","BK0251","300633","SG9999001051.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661624245","title":"股市必读:开立医疗中报 - 第二季度单季净利润同比下降34.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661624245","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661624245?lang=zh_cn&edition=full","pubTime":"2026-08-24 02:44","pubTimestamp":1787510650,"startTime":"0","endTime":"0","summary":"业绩披露要点:2026年中报显示归母净利润1377.63万元,同比下降70.71%。业绩披露要点财务报告2026年中报显示,上半年度主营收入10.53亿元,同比上升9.24%;归母净利润1377.63万元,同比下降70.71%;扣非净利润248.52万元,同比下降93.77%;第二季度单季度主营收入5.73亿元,同比上升7.18%;单季度归母净利润2538.57万元,同比下降34.83%;单季度扣非净利润1677.53万元,同比下降50.48%;负债率26.21%,投资收益37.79万元,财务费用2515.23万元,毛利率60.88%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661216206","title":"开立医疗(300633)6月30日股东户数1.89万户,较上期增加3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661216206","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661216206?lang=zh_cn&edition=full","pubTime":"2026-08-22 17:09","pubTimestamp":1787389785,"startTime":"0","endTime":"0","summary":"证券之星消息,近日开立医疗披露,截至2026年6月30日公司股东户数为1.89万户,较3月31日增加581.0户,增幅为3.17%。在医疗器械行业个股中,开立医疗股东户数低于行业平均水平,截至6月30日,医疗器械行业平均股东户数为2.15万户。从股价来看,2026年3月31日至2026年6月30日,开立医疗区间跌幅为27.38%,在此期间股东户数增加581.0户,增幅为3.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200015087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999006597.SGD","SG9999001069.SGD","SG9999001051.SGD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661294286","title":"图解开立医疗中报:第二季度单季净利润同比下降34.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661294286","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661294286?lang=zh_cn&edition=full","pubTime":"2026-08-22 01:38","pubTimestamp":1787333933,"startTime":"0","endTime":"0","summary":"证券之星消息,开立医疗2026年中报显示,上半年度公司主营收入10.53亿元,同比上升9.24%;归母净利润1377.63万元,同比下降70.71%;扣非净利润248.52万元,同比下降93.77%;其中2026年第二季度,公司单季度主营收入5.73亿元,同比上升7.18%;单季度归母净利润2538.57万元,同比下降34.83%;单季度扣非净利润1677.53万元,同比下降50.48%;负债率26.21%,投资收益37.79万元,财务费用2515.23万元,毛利率60.88%。财报数据概要请见下图:本文数据来源于开立医疗2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200001919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296531","title":"开立医疗(300633)披露2026年股票期权激励计划(草案),8月21日股价下跌0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296531?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:15","pubTimestamp":1787321758,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘,开立医疗报收于20.69元,较前一交易日下跌0.05%,最新总市值为87.9亿元。该股当日开盘20.44元,最高21.2元,最低20.3元,成交额达1.23亿元,换手率为2.27%。近日,深圳开立生物医疗科技股份有限公司披露《2026年股票期权激励计划(草案)》,拟向322名激励对象授予698.20万份股票期权,占公司总股本的1.64%。计划有效期不超过60个月,分四期行权,每期行权比例为25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100045436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","SG9999001051.SGD","300633","SG9999001069.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658060881","title":"股市必读:开立医疗新发布《关于变更持续督导保荐代表人的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658060881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658060881?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:17","pubTimestamp":1786299430,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,开立医疗报收于20.33元,上涨1.25%,换手率2.33%,成交量6.06万手,成交额1.21亿元。原保荐代表人郭小元因个人工作变动不再负责公司2020年度向特定对象发行股票项目的持续督导工作,长城证券指派常晋意接替其职务。本次变更后,持续督导保荐代表人为杨虎和常晋意。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300633","SG9999001069.SGD","SG9999001051.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657623355","title":"开立医疗新注册《开立ED0128D1系列医用内窥镜图像处理器软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2657623355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657623355?lang=zh_cn&edition=full","pubTime":"2026-08-08 02:23","pubTimestamp":1786126991,"startTime":"0","endTime":"0","summary":"证券之星消息,近日开立医疗(300633)新注册了《开立ED0128D1系列医用内窥镜图像处理器软件V1.0》项目的软件著作权。今年以来开立医疗新注册软件著作权12个,较去年同期减少了20%。结合公司2025年年报财务数据,2025年公司在研发方面投入了4.96亿元,同比增4.83%。通过天眼查大数据分析,深圳开立生物医疗科技股份有限公司共对外投资了12家企业,参与招投标项目2508次;财产线索方面有商标信息417条,专利信息1768条,著作权信息339条;此外企业还拥有行政许可297个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080800001155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999006597.SGD","BK0251","SG9999001051.SGD","300633","159180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657164479","title":"开立医疗(300633)披露关于变更持续督导保荐代表人的公告,8月7日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657164479","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657164479?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:29","pubTimestamp":1786112956,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,开立医疗报收于20.33元,较前一交易日上涨1.25%,最新总市值为86.37亿元。开立医疗于2026年8月7日披露《关于变更持续督导保荐代表人的公告》。公告显示,公司近日收到长城证券股份有限公司出具的《关于变更持续督导保荐代表人的通知函》。公司董事会对郭小元先生在持续督导期间的贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","BK0251","300633","SG9999001051.SGD","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654034135","title":"开立医疗获得外观设计专利授权:“显示器(窄边框)”","url":"https://stock-news.laohu8.com/highlight/detail?id=2654034135","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654034135?lang=zh_cn&edition=full","pubTime":"2026-07-25 03:37","pubTimestamp":1784921829,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示开立医疗新获得一项外观设计专利授权,专利名为“显示器(窄边框)”,专利申请号为CN202530717080.1,授权日为2026年7月10日。通过天眼查大数据分析,深圳开立生物医疗科技股份有限公司共对外投资了12家企业,参与招投标项目2485次;财产线索方面有商标信息417条,专利信息1765条,著作权信息339条;此外企业还拥有行政许可294个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072500002409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999006597.SGD","SG9999001051.SGD","BK0251","SG9999001069.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653577810","title":"开立医疗获得实用新型专利授权:“一种医疗设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2653577810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653577810?lang=zh_cn&edition=full","pubTime":"2026-07-24 03:34","pubTimestamp":1784835258,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示开立医疗新获得一项实用新型专利授权,专利名为“一种医疗设备”,专利申请号为CN202521166217.X,授权日为2026年7月24日。通过天眼查大数据分析,深圳开立生物医疗科技股份有限公司共对外投资了12家企业,参与招投标项目2478次;财产线索方面有商标信息417条,专利信息1759条,著作权信息339条;此外企业还拥有行政许可293个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400004088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159873","SG9999006597.SGD","SG9999001069.SGD","SG9999001051.SGD","300633"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650132079","title":"开立医疗获得发明专利授权:“一种图像渲染方法、装置、电子设备及可读存储介质”","url":"https://stock-news.laohu8.com/highlight/detail?id=2650132079","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650132079?lang=zh_cn&edition=full","pubTime":"2026-07-11 03:53","pubTimestamp":1783713196,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示开立医疗新获得一项发明专利授权,专利名为“一种图像渲染方法、装置、电子设备及可读存储介质”,专利申请号为CN202111462446.2,授权日为2026年7月10日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071100003311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999001051.SGD","300633","BK0251","SG9999006597.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791987365680,"stockEarnings":[{"period":"1week","weight":-0.0391},{"period":"1month","weight":-0.0312},{"period":"3month","weight":-0.0291},{"period":"6month","weight":-0.3099},{"period":"1year","weight":-0.4479},{"period":"ytd","weight":-0.2872}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳开立生物医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"18913人(较上一季度增加3.17%)","perCapita":"13753股","listingDate":"2017-04-06","address":"广东省深圳市南山区粤海街道麻岭社区高新中区科技中2路1号深圳软件园(2期)12栋201、202","registeredCapital":"42483万元","survey":" 深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是超声诊断仪、消化与呼吸内镜、微创外科产品以及心血管介入产品。截至报告期末,公司及其子公司已拥有境内外各项发明专利、实用新型专利及外观设计专利共计1254项,拥有软件著作权共344项、作品著作权30项,产品技术达到国内领先和国际先进水平。公司自2009年起被持续认定为“国家级高新技术企业”。","listedPrice":5.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开立医疗,300633,开立医疗股票,开立医疗股票老虎,开立医疗股票老虎国际,开立医疗行情,开立医疗股票行情,开立医疗股价,开立医疗股市,开立医疗股票价格,开立医疗股票交易,开立医疗股票购买,开立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}